Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label
Biomarkers
Genomics, transcriptomics and proteomics analyses to determine presence or absence of biomarkers
within twenty four hours
No
Marine GILABERT, MD
Principal Investigator
Institut Paoli-Calmettes
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
PACAomics / IPC 2011-004
NCT01692873
February 2012
February 2015
Name | Location |
---|